Manage and Prevent Cancer-Associated VTE

August 2024

You’ll get questions about treating and preventing cancer-associated venous thromboembolism (VTE).

It’s tricky...since these patients often have an increased risk of thrombosis AND bleeding.

Be prepared to guide options...and help avoid errors.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote